[1]
V. Kukongviriyapan and A. Prawan, “Pharmacogenetics of Drug Metabolizing Enzymes in Association with Cholangiocarcinoma Risk”, SRIMEDJ, vol. 27, pp. 413–421, Aug. 2013.